Target intelligence / Profile preview

Cytokine milieu and chemokine axes

Molecular classification
Cytokine, Chemokine, G protein-coupled receptor, Soluble mediator
01

Overview

The cytokine milieu and chemokine axes represent the complex network of signaling proteins and their corresponding receptors that coordinate immune cell communication and trafficking. The cytokine milieu refers to the specific composition and concentration of cytokines in a tissue or systemic environment, which determines the nature of the immune response, such as pro-inflammatory or anti-inflammatory states (Nature Reviews Immunology, 2021). Chemokine axes, such as the CXCL12-CXCR4 or CCL2-CCR2 pathways, are specific signaling pairs that direct the migration of leukocytes to sites of injury, infection, or malignancy (Frontiers in Immunology, 2020). In disease states like cancer, the tumor microenvironment often hijacks these axes to promote immunosuppression, angiogenesis, and metastasis (Cell, 2019). Therapeutic intervention involves the use of monoclonal antibodies or small molecule inhibitors to disrupt these signals, thereby modulating the immune landscape to treat inflammatory disorders and various malignancies (Journal of Clinical Investigation, 2018). Because this term encompasses hundreds of distinct proteins and pathways, it is categorized as a biological system rather than a single drugable target.

Other names
Cytokine environmentChemokine signaling networkInflammatory milieuCytokine-chemokine network
02

Mechanism of action

Drugs targeting these axes typically function by neutralizing soluble cytokines with monoclonal antibodies, blocking cytokine receptors, or antagonizing G protein-coupled chemokine receptors to prevent cellular recruitment and signaling.

03

Biological functions

Immune responseCell migrationInflammationSignal transductionLeukocyte trafficking
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionCardiovascular disease
05

Safety considerations

Increased risk of infectionImmunosuppressionCytokine release syndromeImpaired wound healing
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6) levelsTumor Necrosis Factor-alpha (TNF-α) levelsC-reactive protein (CRP)CXCL12 expression

Beyond the preview

Go deeper on Cytokine milieu and chemokine axes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine milieu and chemokine axes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call